Fairvalue-Calculator Fairvalue-Calculator
EN DE

Allgens Medical Technology CO., LTD. (688613) Fair Value & Analysis

Healthcare · CN · Market cap 2.2B CNY

Price¥15.29
Fair Value¥2.11
Upside-86.2%
Quality94/100
Evidence: High Range ¥1.60 – ¥2.64

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Allgens Medical Technology CO., LTD. (688613) currently trades at ¥15.29, while our model-based Fair Value estimate is ¥2.11 — implying the stock looks roughly 86.2% overvalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Allgens Medical Technology CO., LTD. engages in the research and development, production, and sale of biomedical materials and related medical device products in China. The company offers collagen artificial bone repair materials to agents and terminal hospitals. Its products include Tooth Shell for the treatment of oral or plastic surgery and BonGold for the treatment of orthopedic bone defect repair. The company was founded in 2004 and is based in Beijing, China.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Allgens Medical Technology CO., LTD. (688613) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥2.11 versus a price of ¥15.29 — about −86% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 688613?
Our 21-model fair value for Allgens Medical Technology CO., LTD. is ¥2.11 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥15.29.
What is the quality score of 688613?
Allgens Medical Technology CO., LTD. has a Quality Score of 94/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.